UnknownNot applicableNCT00577967

Gabapentin - A Solution to Uremic Pruritus?

Studying Uremic pruritus

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Hospital Authority, Hong Kong
Principal Investigator: Yui Pong Siu, Dr
Medical and Geriatrics / Nephrology, Tuen Mun Hospital
Intervention: Gabapentin(drug)
Enrollment: 80 target
Eligibility: All sexes
Timeline: 2005 – 2006

Study locations (1)

Tuen Mun Hospital, Hong Kong, China

Collaborators

Pfizer

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00577967 on ClinicalTrials.gov

Other trials for Uremic pruritus

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE3NCT06446310
Phase 3 Study of QLG2198 in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus
Qilu Pharmaceutical (Hainan) Co., Ltd.

See all trials for Uremic pruritus →

← Back to all trials